1 Discovering drugs to treat coronavirus disease 2019[COVID-19]
来源：DRUG DISCOV THER( P 1881-7831 E 1881-784X ) 发表时间: 2020/02
类型：期刊论文 为本人加分：7092.486987
贡献度：单独通讯作者
2 Nosocomial infection and its molecular mechanisms of antibiotic resistance
来源：BIOSCI TRENDS( P 1881-7815 E 1881-7823 ) 发表时间: 2016/02
类型：期刊论文 为本人加分：6226.591240
3 Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma
来源：WORLD J GASTROENTERO( P 1007-9327 E 2219-2840 ) 发表时间: 2015/11
类型：期刊论文 为本人加分：5237.731104
4 Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carcinoma cells
来源：ACTA PHARMACOL SIN( P 1671-4083 E 1745-7254 ) 发表时间: 2020/12
类型：期刊论文 为本人加分：3789.653926
5 Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carc..
来源：DRUG DISCOV THER( P 1881-7831 E 1881-784X ) 发表时间: 2017/06
类型：期刊论文 为本人加分：3351.249498
6 Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse x..
来源：ACTA PHARMACOL SIN( P 1671-4083 E 1745-7254 ) 发表时间: 2018/03
类型：期刊论文 为本人加分：2247.466760
7 Research progress on the direct antiviral drugs for hepatitis C virus
来源：BIOSCI TRENDS( P 1881-7815 E 1881-7823 ) 发表时间: 2017/01
类型：期刊论文 为本人加分：2170.763399
8 Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019[COVID-19]
来源：BIOSCI TRENDS( P 1881-7815 E 1881-7823 ) 发表时间: 2020/04
类型：期刊论文 为本人加分：2118.563399
贡献度：单独第一作者;单独通讯作者
9 Biomarkers: Evaluation of Screening for and Early Diagnosis of Hepatocellular Carcinoma in Japan and..
来源：LIVER CANCER( P 2235-1795 E 1664-5553 ) 发表时间: 2013/01
类型：期刊论文 为本人加分：1899.269828
10 Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer..
来源：INTRACTABLE RARE DIS( P 2186-3644 E 2186-361X ) 发表时间: 2013/02
类型：期刊论文 为本人加分：1779.829616